Luz Vanessa C C, Pereira Sónia Gonçalves
Center for Innovative Care and Health Technology, School of Health Sciences, Polytechnic of Leiria, Leiria, Portugal.
Front Med Technol. 2024 Sep 16;6:1413637. doi: 10.3389/fmedt.2024.1413637. eCollection 2024.
Celiac disease is an autoimmune enteropathy caused by the ingestion of minute amounts of gluten in a subset of genetically predisposed individuals. Its onset occurs at different ages and with variable symptoms. The gut microbiome may contribute to this variability. This review aims to provide an overview of the available research on celiac disease gut microbiome and identify the knowledge gap that could guide future studies. Following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-analysis extension for Scoping Reviews (PRISMA-ScR), four electronic databases were searched for literature from January 2000 to July 2023 addressing celiac disease gut microbiome characterization using next-generation sequencing (NGS) approaches. From the 489 publications retrieved, 48 publications were selected and analyzed, focusing on sample characterization (patients, controls, and tissues) and methodologies used for NGS microbiome analysis and characterization. The majority of the selected publications regarded children and adults, and four were randomized clinical trials. The number of participants per study greatly varied and was typically low. Feces were the most frequently tested sample matrix, and duodenal samples were analyzed in one-third of the studies. Incomplete and diverse information on the methodological approaches and gut microbiome results was broadly observed. While similar trends regarding the relative abundance of some phyla, such as Pseudomonadota (former Proteobacteria), were detected in some studies, others contradicted those results. The observed high variability of technical approaches and possibly low power and sample sizes may prevent reaching a consensus on celiac disease gut microbiome composition. Standardization of research protocols to allow reproducibility and comparability is required, as interdisciplinary collaborations to further data analysis, interpretation, and, more importantly, health outcome prediction or improvement.
乳糜泻是一种自身免疫性肠病,由一小部分具有遗传易感性的个体摄入微量麸质引起。其发病发生在不同年龄,症状多样。肠道微生物群可能导致了这种变异性。本综述旨在概述关于乳糜泻肠道微生物群的现有研究,并确定可指导未来研究的知识空白。按照系统评价和Meta分析扩展的范围综述的首选报告项目指南(PRISMA-ScR),检索了四个电子数据库,以获取2000年1月至2023年7月期间使用下一代测序(NGS)方法对乳糜泻肠道微生物群进行表征的文献。从检索到的489篇出版物中,选择并分析了48篇出版物,重点关注样本特征(患者、对照和组织)以及用于NGS微生物群分析和表征的方法。所选出版物大多涉及儿童和成人,其中四项是随机临床试验。每项研究的参与者数量差异很大,通常较少。粪便样本是最常检测的样本基质,三分之一的研究分析了十二指肠样本。广泛观察到关于方法学方法和肠道微生物群结果的信息不完整且多样。虽然在一些研究中检测到了某些门(如假单胞菌门(原变形菌门))相对丰度的类似趋势,但其他研究与这些结果相矛盾。观察到的技术方法的高度变异性以及可能较低的效能和样本量可能会阻碍就乳糜泻肠道微生物群组成达成共识。需要对研究方案进行标准化,以实现可重复性和可比性,因为需要跨学科合作来进一步进行数据分析、解释,更重要的是进行健康结果预测或改善。